Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical Inc (NQ: NARI )

61.20 +1.51 (+2.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Inari Medical Inc

Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally 
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Closes Acquisition of LimFlow
From Inari Medical, Inc.
Via GlobeNewswire
After blowout earnings, Integer may be headed to new highs
A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024. 
Via MarketBeat
Topics Economy
Exposures Supply Chain
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports Third Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Third Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces the Release of 2022 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the Bank of America 2023 Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports Third Quarter 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces In-hospital and 30-day Outcomes from the Fully Enrolled CLOUT Registry and Results from Propensity-Score Matched Comparison of CLOUT vs. ATTRACT
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Third Quarter 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.